The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shearer, G. M.
Right arrow Articles by Gallo, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shearer, G. M.
Right arrow Articles by Gallo, R. C.

The Journal of Immunology, Vol 137, Issue 8 2514-2521, Copyright © 1986 by American Association of Immunologists


ARTICLES

A model for the selective loss of major histocompatibility complex self- restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS)

GM Shearer, DC Bernstein, KS Tung, CS Via, R Redfield, SZ Salahuddin and RC Gallo

Functional analyses of peripheral blood leukocytes (PBL) from high risk HTLV-III antibody-negative and antibody-positive donors, as well as from patients with acquired immune deficiency syndrome (AIDS), lymphadenopathy syndrome (LAS), and AIDS-related complex (ARC) were performed by the in vitro generation of cytotoxic T lymphocyte (CTL) and proliferative responses to the HLA self-restricted antigens of influenza virus (S + X) and to nonself restricted HLA alloantigens (ALLO). All 40 antibody-negative donors tested responded to both S + X and ALLO in the CTL response, whereas six of 14 antibody-positive, two of three LAS, four of five ARC, and seven of 17 AIDS patients exhibited a selective absence of CTL to S + X, but generated normal or elevated CTL responses to ALLO. Of the remaining 10 AIDS patients, nine did not respond to either S + X or ALLO, and one responded to both S + X and ALLO. A similar selective loss of the proliferative response to S + X was found. We also observed antibody-positive donors who initially generated CTL responses to S + X and ALLO, but lost the S + X response as a function of time. We were able to restore the selective loss of S + X CTL activity in vitro by the addition of IL 2 and, to some extent, by co-stimulation with S + X plus ALLO. Depletion of CD4+ T helper cells and removal of autologous antigen-presenting cells from the PBL of healthy antibody-negative donors indicated that distinct T helper cell subsets exist in human PBL, and that S + X responses must use a CD4+ T helper population, whereas ALLO responses can utilize an alternate CD4- T helper pathway. A model is presented indicating the selective depletion of CD4+ T helper function in the developmental stages of AIDS. The functional test for T helper activity to self restricted antigens may be the earliest indicator of immune functional loss in the development of AIDS, and may precede a reduction in the absolute number of CD4+ cells.


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Guan, M. Moretto, D. J. Bzik, J. Gigley, and I. A. Khan
NK Cells Enhance Dendritic Cell Response against Parasite Antigens via NKG2D Pathway
J. Immunol., July 1, 2007; 179(1): 590 - 596.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. M. Beck
The Immunocompromised Host: HIV Infection
Proceedings of the ATS, December 1, 2005; 2(5): 423 - 427.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. L. Combe, T. J. Curiel, M. M. Moretto, and I. A. Khan
NK Cells Help To Induce CD8+-T-Cell Immunity against Toxoplasma gondii in the Absence of CD4+ T Cells
Infect. Immun., August 1, 2005; 73(8): 4913 - 4921.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Moretto, L. Casciotti, B. Durell, and I. A. Khan
Lack of CD4+ T Cells Does Not Affect Induction of CD8+ T-Cell Immunity against Encephalitozoon cuniculi Infection
Infect. Immun., November 1, 2000; 68(11): 6223 - 6232.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
T. Messele, M. T. L. Roos, D. Hamann, M. Koot, A. L. Fontanet, F. Miedema, P. T. A. Schellekens, and T. F. Rinke de Wit
Nonradioactive Techniques for Measurement of In Vitro T-Cell Proliferation: Alternatives to the [3H]Thymidine Incorporation Assay
Clin. Vaccine Immunol., July 1, 2000; 7(4): 687 - 692.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Cicala, J. Arthos, A. Rubbert, S. Selig, K. Wildt, O. J. Cohen, and A. S. Fauci
HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4+ T cells
PNAS, February 1, 2000; 97(3): 1178 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
I. A. Khan, W. R. Green, L. H. Kasper, K. A. Green, and J. D. Schwartzman
Immune CD8+ T Cells Prevent Reactivation of Toxoplasma gondii Infection in the Immunocompromised Host
Infect. Immun., November 1, 1999; 67(11): 5869 - 5876.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. B. Urnovitz, J. C. Sturge, T. D. Gottfried, and W. H. Murphy
Urine Antibody Tests: New Insights into the Dynamics of HIV-1 Infection
Clin. Chem., September 1, 1999; 45(9): 1602 - 1613.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Segura, C. Delmelle-Wibaut, M. Janssens, Y. Cleuter, A. van den Broeke, R. Kettmann, and K. E. Willard-Gallo
Human Immunodeficiency Virus Type 2 Produces a Defect in CD3-gamma Gene Transcripts Similar to That Observed for Human Immunodeficiency Virus Type 1
J. Virol., June 1, 1999; 73(6): 5207 - 5213.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
N. Selliah and T. H. Finkel
Cutting Edge: JAK3 Activation and Rescue of T Cells from HIV gp120-Induced Unresponsiveness
J. Immunol., June 15, 1998; 160(12): 5697 - 5701.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. A. Trimble and J. Lieberman
Circulating CD8 T Lymphocytes in Human Immunodeficiency Virus-Infected Individuals Have Impaired Function and Downmodulate CD3zeta , the Signaling Chain of the T-Cell Receptor Complex
Blood, January 15, 1998; 91(2): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Herbein, C. Van Lint, J. L. Lovett, and E. Verdin
Distinct Mechanisms Trigger Apoptosis in Human Immunodeficiency Virus Type 1-Infected and in Uninfected Bystander T Lymphocytes
J. Virol., January 1, 1998; 72(1): 660 - 670.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. X. Wu and S. F. Schlossman
Decreased ability of HIV-1 Tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells
PNAS, December 9, 1997; 94(25): 13832 - 13837.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. J. Phipps, S. Yousefi, and D. R. Branch
Increased Enzymatic Activity of the T-Cell Antigen Receptor-Associated Fyn Protein Tyrosine Kinase in Asymptomatic Patients Infected With the Human Immunodeficiency Virus
Blood, November 1, 1997; 90(9): 3603 - 3612.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Meyaard, E. Hovenkamp, N. Pakker, T. C.T.M. van der Pouw Kraan, and F. Miedema
Interleukin-12 (IL-12) Production in Whole Blood Cultures From Human Immunodeficiency Virus-Infected Individuals Studied in Relation to IL-10 and Prostaglandin E2 Production
Blood, January 15, 1997; 89(2): 570 - 576.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Viscidi, K Mayur, H. Lederman, and A. Frankel
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1
Science, December 22, 1989; 246(4937): 1606 - 1608.
[Abstract] [PDF]


Home page
ScienceHome page
A. Fauci
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis
Science, February 5, 1988; 239(4840): 617 - 622.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1986 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1986 by The American Association of Immunologists, Inc. All rights reserved.